+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rapid STI Testing Market Size, Share & Trends Analysis Report 2026-2033- Product Image
Rapid STI Testing Market Size, Share & Trends Analysis Report 2026-2033- Product Image
New

Rapid STI Testing Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2026
  • Region: Global
  • Grand View Research
  • ID: 6288650
REQUEST CUSTOMIZATION
Description Jump to:
The global rapid STI testing market size was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to USD 2.8 billion by 2033, at a CAGR of 8.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.1% in 2025. Market growth is primarily driven by the rising global burden of sexually transmitted infections, which is increasing demand for rapid, accessible, and timely diagnostic testing

Global Rapid STI Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Single-target Tests has segmented the Rapid STI testing market report on the basis of technology, infection type, test type, sample type, end use and region.

Technology Outlook (Revenue, USD Million, 2021 - 2033)

  • Molecular Diagnostics / NAAT
  • Rapid Immunoassays
  • Others

Infection Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Chlamydia
  • Gonorrhea
  • SYPHILIS
  • TRICHOMONIASIS
  • Mycoplasma genitalium
  • Multiple STI Targets
  • Other STI Targets

Test Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Single-target Tests
  • Multiplex / Combination Tests

Sample Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Urine
  • Swab Specimens
  • Whole Blood / Serum / Plasma
  • Other Specimens

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics
  • Diagnostic Laboratories & Near-Point-of-Care Facilities
  • Public Health & Community Testing Settings
  • Home / Self-testing
  • Other End Uses

Rapid STI Testing Market Regional Outlook (Revenue, USD Million; 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Technology Segment
1.2.2. Infection Type Segment
1.2.3. Test Type Segment
1.2.4. Sample Type Segment
1.2.5. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Rapid STI Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological Innovation in Rapid STI Diagnostic Technologies and Point-of-Care Testing
3.2.1.2. Growing Global Burden of Sexually Transmitted Infections
3.2.1.3. Increasing Adoption of Decentralized and Point-of-Care STI Testing
3.2.2. Market restraint analysis
3.2.2.1. Regulatory, Performance, and Cost Barriers Limiting Rapid STI Testing Adoption
3.2.2.2. Risk of False-Positive and False-Negative Results
3.2.3. Market opportunity analysis
3.3. Global Rapid STI Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Global Rapid STI Testing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Rapid STI Testing Market Technology Movement Analysis
4.3. Global Rapid STI Testing Market Size & Trend Analysis by Technology, 2021 to 2033 (USD Million)
4.4. Molecular Diagnostics / NAAT
4.4.1. Molecular Diagnostics / NAAT market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Rapid Immunoassays
4.5.1. Rapid Immunoassays market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Global Rapid STI Testing Market: Infection Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Rapid STI Testing Market Infection Type Movement Analysis
5.3. Global Rapid STI Testing Market Size & Trend Analysis, Infection Type, 2021 to 2033 (USD Million)
5.4. Chlamydia
5.4.1. Chlamydia market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Gonorrhea
5.5.1. Gonorrhea market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Syphilis
5.6.1. Syphilis market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Trichomoniasis
5.7.1. Trichomoniasis market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Mycoplasma genitalium
5.8.1. Mycoplasma genitalium market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Multiple STI Targets
5.9.1. Multiple STI Targets market estimates and forecasts 2021 to 2033 (USD Million)
5.10. Other
5.10.1. Other market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Global Rapid STI Testing Market: Test Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Rapid STI Testing Market Test Type Movement Analysis
6.2.1. Global Rapid STI Testing Market Size & Trend Analysis, Test Type, 2021 to 2033 (USD Million)
6.3. Single-target Tests
6.3.1. Single-target Tests market estimates and forecasts 2021 to 2033 (USD Million)
6.4. Multiplex / Combination Tests
6.4.1. Multiplex / Combination Tests market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Global Rapid STI Testing Market: Sample Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Rapid STI Testing Market Sample Type Movement Analysis
7.2.1. Global Rapid STI Testing Market Size & Trend Analysis, Sample Type, 2021 to 2033 (USD Million)
7.3. Urine
7.3.1. Urine market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Swab Specimens
7.4.1. Swab Specimens market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Whole Blood / Serum / Plasma
7.5.1. Whole Blood / Serum / Plasma market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Other Specimens
7.6.1. Other Specimens market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Global Rapid STI Testing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Rapid STI Testing Market End Use Movement Analysis
8.2.1. Global Rapid STI Testing Market Size & Trend Analysis, End Use, 2021 to 2033 (USD Million)
8.3. Hospitals & Clinics
8.3.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
8.4. Diagnostic Laboratories & Near-Point-of-Care Facilities
8.4.1. Diagnostic Laboratories & Near-Point-of-Care Facilities market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Public Health & Community Testing Settings
8.5.1. Public Health & Community Testing Settings market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Home / Self-testing
8.6.1. Home / Self-testing market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Other End Uses
8.7.1. Other End Uses market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Rapid STI Testing Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2025
10.4. List of Key Certification Providers/Scheme Owners
10.5. Company Profiles/Listing
10.5.1. Danaher Corporation
10.5.1.1. Company overview
10.5.1.2. Financial performance
10.5.1.3. Technology benchmarking
10.5.1.4. Strategic initiatives
10.5.2. F. Hoffmann-La Roche Ltd
10.5.2.1. Company overview
10.5.2.2. Financial performance
10.5.2.3. Product benchmarking
10.5.2.4. Strategic initiatives
10.5.3. Abbott
10.5.3.1. Company overview
10.5.3.2. Financial performance
10.5.3.3. Product benchmarking
10.5.3.4. Strategic initiatives
10.5.4. Visby Medical, Inc.
10.5.4.1. Company overview
10.5.4.2. Financial performance
10.5.4.3. Product benchmarking
10.5.4.4. Strategic initiatives
10.5.5. SD Biosensor, INC.
10.5.5.1. Company overview
10.5.5.2. Financial performance
10.5.5.3. Product benchmarking
10.5.5.4. Strategic initiatives
10.5.6. Premier Medical
10.5.6.1. Company overview
10.5.6.2. Financial performance
10.5.6.3. Product benchmarking
10.5.6.4. Strategic initiatives
10.5.7. bioLytical Laboratories Inc.
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Biosynex SA
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. Trinity Biotech plc
10.5.9.1. Company overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. Guangzhou Wondfo Biotech Co., Ltd
10.5.10.1. Company overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
10.5.11. InTec Products, Inc.
10.5.11.1. Company overview
10.5.11.2. Financial performance
10.5.11.3. Product benchmarking
10.5.11.4. Strategic initiatives
10.5.12. Access Bio, Inc.
10.5.12.1. Company overview
10.5.12.2. Financial performance
10.5.12.3. Product benchmarking
10.5.12.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 4 Global Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 5 Global Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 6 Global Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 7 Global Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 8 North America Rapid STI Testing Market, region, 2021- 2033 (USD Million)
Table 9 North America Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 10 North America Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 11 North America Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 12 North America Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 13 North America Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 14 U.S. Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 15 U.S. Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 16 U.S. Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 17 U.S. Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 18 U.S. Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 19 Canada Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 20 Canada Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 21 Canada Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 22 Canada Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 23 Canada Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 24 Mexico Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 25 Mexico Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 26 Mexico Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 27 Mexico Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 28 Mexico Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 29 Europe Rapid STI Testing Market, region, 2021- 2033 (USD Million)
Table 30 Europe Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 31 Europe Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 32 Europe Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 33 Europe Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 34 Europe Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 35 UK Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 36 UK Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 37 UK Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 38 UK Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 39 UK Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 40 Germany Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 41 Germany Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 42 Germany Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 43 Germany Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 44 Germany Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 45 France Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 46 France Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 47 France Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 48 France Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 49 France Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 50 Italy Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 51 Italy Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 52 Italy Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 53 Italy Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 54 Italy Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 55 Spain Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 56 Spain Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 57 Spain Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 58 Spain Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 59 Spain Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 60 Denmark Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 61 Denmark Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 62 Denmark Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 63 Denmark Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 64 Denmark Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 65 Sweden Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 66 Sweden Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 67 Sweden Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 68 Sweden Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 69 Sweden Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 70 Norway Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 71 Norway Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 72 Norway Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 73 Norway Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 74 Norway Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 75 Asia Pacific Rapid STI Testing Market, region, 2021- 2033 (USD Million)
Table 76 Asia Pacific Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 77 Asia Pacific Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 78 Asia Pacific Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 79 Asia Pacific Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 80 Asia Pacific Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 81 Japan Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 82 Japan Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 83 Japan Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 84 Japan Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 85 Japan Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 86 China Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 87 China Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 88 China Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 89 China Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 90 China Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 91 India Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 92 India Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 93 India Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 94 India Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 95 India Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 96 Australia Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 97 Australia Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 98 Australia Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 99 Australia Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 100 Australia Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 101 South Korea Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 102 South Korea Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 103 South Korea Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 104 South Korea Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 105 South Korea Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 106 Thailand Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 107 Thailand Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 108 Thailand Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 109 Thailand Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 110 Thailand Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 111 Latin America Rapid STI Testing Market, region, 2021- 2033 (USD Million)
Table 112 Latin America Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 113 Latin America Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 114 Latin America Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 115 Latin America Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 116 Latin America Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 117 Brazil Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 118 Brazil Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 119 Brazil Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 120 Brazil Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 121 Brazil Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 122 Argentina Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 123 Argentina Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 124 Argentina Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 125 Argentina Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 126 Argentina Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 127 MEA Rapid STI Testing Market, region, 2021- 2033 (USD Million)
Table 128 MEA Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 129 MEA Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 130 MEA Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 131 MEA Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 132 MEA Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 133 South Africa Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 134 South Africa Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 135 South Africa Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 136 South Africa Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 137 South Africa Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 138 Saudi Arabia Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 139 Saudi Arabia Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 140 Saudi Arabia Rapid STI Testing Market, Test Type, 2021 - 20332021 - 20332021 - 2033 (USD Million)
Table 141 Saudi Arabia Rapid STI Testing Market, Sample Type, 2021 - 20332021 - 20332021 - 2033 (USD Million)
Table 142 Saudi Arabia Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
Table 143 UAE Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 144 UAE Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 145 UAE Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 146 UAE Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 147 Kuwait Rapid STI Testing Market, Technology, 2021- 2033 (USD Million)
Table 148 Kuwait Rapid STI Testing Market, Infection Type, 2021- 2033 (USD Million)
Table 149 Kuwait Rapid STI Testing Market, Test Type, 2021 - 2033 (USD Million)
Table 150 Kuwait Rapid STI Testing Market, Sample Type, 2021 - 2033 (USD Million)
Table 151 Kuwait Rapid STI Testing Market, End Use, 2021- 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Rapid STI Testing Market: Market outlook
Figure 9 Rapid STI Testing Market: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Rapid STI testing market driver impact
Figure 15 Rapid STI testing market restraint impact
Figure 16 Rapid STI testing market strategic initiatives analysis
Figure 17 Rapid STI testing market: Technology movement analysis
Figure 18 Rapid STI testing market: Technology outlook and key takeaways
Figure 19 Rapid Immunoassays & systems market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 20 Molecular Diagnostics / NAAT market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 21 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 22 Rapid STI testing market: Infection Type movement analysis
Figure 23 Rapid STI testing market: Infection Type outlook and key takeaways
Figure 24 Chlamydia market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 25 Gonorrhea market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 26 Syphilis market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 27 Trichomoniasis market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 28 Mycoplasma genitalium market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 29 Multiple STI Targets market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 30 Other market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 31 Rapid STI testing market: Test Type movement analysis
Figure 32 Rapid STI testing market: Test Type outlook and key takeaways
Figure 33 Single-target Tests market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 34 Multiplex / Combination Tests market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 35 Rapid STI testing market: Sample Type movement analysis
Figure 36 Rapid STI testing market: Sample Type outlook and key takeaways
Figure 37 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 38 Swab Specimens market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 39 Whole Blood / Serum / Plasma market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 40 Other Specimens market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 41 Rapid STI testing market: End Use movement analysis
Figure 42 Rapid STI testing market: End Use outlook and key takeaways
Figure 43 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 44 Hospitals & diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 45 Pharma & biotech companies market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 46 Home / Self-testing market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 47 Other End Uses market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 48 Global Rapid STI testing market: Regional movement analysis
Figure 49 Global Rapid STI testing market: Regional outlook and key takeaways
Figure 50 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 51 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 52 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 53 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 54 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 55 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 56 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 57 France market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 58 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 59 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 60 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 61 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 63 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 64 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 65 China market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 66 India market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 67 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 68 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 69 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 71 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 72 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 73 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 74 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 75 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 76 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 77 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Visby Medical, Inc.
  • SD Biosensor, INC
  • Premier Medical
  • bioLytical Laboratories Inc.
  • Biosynex SA
  • Trinity Biotech plc
  • Guangzhou Wondfo Biotech Co., Ltd.
  • InTec Products, Inc.
  • Access Bio, Inc.

Related Reports

At-Home STI Testing Market Size, Share & Trends Analysis Report by Infection, Test Type, Sample Type, Distribution Channel, Region, and Segment Forecasts, 2026-2033 - Product Image

At-Home STI Testing Market Size, Share & Trends Analysis Report by Infection, Test Type, Sample Type, Distribution Channel, Region, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
U.S. Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product (Instruments & Services, Consumables), By Application (Chlamydia Testing, Syphilis Testing), By Technology, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product (Instruments & Services, Consumables), By Application (Chlamydia Testing, Syphilis Testing), By Technology, And Segment Forecasts, 2025 - 2033

  • Report
  • 137 Pages
  • United States
From
U.S. HSV Testing Market Size, Share & Trends Analysis by Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), by Test Type, by Sample Type (Blood, Swabs, Cerebrospinal Fluid), by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

U.S. HSV Testing Market Size, Share & Trends Analysis by Type (HSV-1/HSV-2 Combines, HSV-1, HSV-2), by Test Type, by Sample Type (Blood, Swabs, Cerebrospinal Fluid), by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • United States
From
Self-Testing Market Size, Share & Trends Analysis Report by Product, Sample, Application, Distribution Channel, Usage, Region, and Growth Forecasts, 2026-2033 - Product Image

Self-Testing Market Size, Share & Trends Analysis Report by Product, Sample, Application, Distribution Channel, Usage, Region, and Growth Forecasts, 2026-2033

  • Report
  • 160 Pages
  • Global
From
Rapid Tests Market Size, Share & Trends Analysis Report by Product, Technology, Application, End Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Rapid Tests Market Size, Share & Trends Analysis Report by Product, Technology, Application, End Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.